# A Multi-Center Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Body Composition and Metabolic Parameters With Diet and Exercise in Conjunction With Treatment With 12.5 mg or 25 mg Enclomiphene

> **NCT02651688** · PHASE2 · COMPLETED · sponsor: **Repros Therapeutics Inc.** · enrollment: 50 (actual)

## Conditions studied

- Acquired Hypogonadotropic Hypogonadism
- Obesity

## Interventions

- **DRUG:** Placebo
- **DRUG:** Enclomiphene

## Key facts

- **NCT ID:** NCT02651688
- **Lead sponsor:** Repros Therapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01-11
- **Primary completion:** 2017-05-02
- **Final completion:** 2017-05-02
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2019-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02651688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02651688, "A Multi-Center Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Body Composition and Metabolic Parameters With Diet and Exercise in Conjunction With Treatment With 12.5 mg or 25 mg Enclomiphene". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02651688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*